Rakovina Therapeutics Inc (RKV) — Financial Flexibility Index

Latest as of September 2025: -0.31x

Rakovina Therapeutics Inc (RKV) has a Financial Flexibility Index of -0.31x as of September 2025. Free cash flow of CA$-1.04 Million (operating CF CA$-1.04 Million minus capex CA$0.00) represents 0% of total liabilities (CA$3.38 Million). Check RKV tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-0.31x
Free Cash Flow / Total Liabilities

Free Cash Flow

CA$-1.04 Million
Operating CF − Capex

Total Liabilities

CA$3.38 Million
CAD

Capital Expenditures

CA$0.00
CAD

Rakovina Therapeutics Inc Financial Flexibility Index (2021–2024)

Historical Financial Flexibility Index trend for Rakovina Therapeutics Inc across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does Rakovina Therapeutics Inc generate cash.

Annual Financial Flexibility Index for Rakovina Therapeutics Inc (2021–2024)

Year-by-year free cash flow to debt coverage for Rakovina Therapeutics Inc. Explore debt repayment capacity of Rakovina Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (CAD) Operating CF Total Liabilities YoY Change
2024 -1.99x CA$-3.86 Million CA$-3.86 Million CA$1.94 Million ▼ -58.6%
2023 -1.25x CA$-1.86 Million CA$-1.86 Million CA$1.49 Million ▲ +93.0%
2022 -17.91x CA$-1.92 Million CA$-1.92 Million CA$107.05K ▲ +11.6%
2021 -20.25x CA$-2.31 Million CA$-2.31 Million CA$113.98K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities